Plus Library

Displaying 1,526 - 1,550 of 2,875

Immunotherapy in Lung Cancer
Immunotherapy in Lung Cancer
Edgardo S. Santos Castillero, M.D
Immunotherapy in Lung Cancer
Immunotherapy in Lung Cancer
Edgardo S. Santos Castillero, M.D
EGFR and K-RAS Mutations in NSCLC
EGFR and K-RAS Mutations in NSCLC
Edgardo S. Santos Castillero, MD
EGFR and K-RAS Mutations in NSCLC
EGFR and K-RAS Mutations in NSCLC
Edgardo S. Santos Castillero, MD
RET, MET, and BRAF Mutant Lung Cancer Tumors
RET, MET, and BRAF Mutant Lung Cancer Tumors
Edgardo S. Santos Castillero, MD, FACP
EGFR, K-RAS and ERBB2 Mutations in NSCLC
EGFR, K-RAS and ERBB2 Mutations in NSCLC
Edgardo S. Santos Castillero, MD, FACP
EGFR, K-RAS and ERBB2 Mutations in NSCLC
EGFR, K-RAS and ERBB2 Mutations in NSCLC
Edgardo S. Santos Castillero, MD, FACP
Novel Treatment for Unresectable Stage III NSCLC
Novel Treatment for Unresectable Stage III NSCLC
Edgardo S. Santos Castillero, MD, FACP
Novel Treatment for Unresectable Stage III NSCLC
Novel Treatment for Unresectable Stage III NSCLC
Edgardo S. Santos Castillero, MD, FACP
Small Cell Lung Cancer
Small Cell Lung Cancer
Edgardo S. Santos Castillero, MD, FACP, FASCO
HER-3 as a New Target in NSCLC
HER-3 as a New Target in NSCLC
Edgardo S. Santos, MD